Cargando…

Inflammatory bowel disease and the lung in paediatric patients

The prevalence of inflammatory bowel disease (IBD) has increased over the past 20 years. Pulmonary involvement in paediatric IBD is rare but may be missed since the spectrum of symptoms is broad and mimics other diseases. The most important differential diagnoses of pulmonary manifestations of IBD a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jochmann, Anja, Trachsel, Daniel, Hammer, Jürg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291939/
https://www.ncbi.nlm.nih.gov/pubmed/34295391
http://dx.doi.org/10.1183/20734735.0269-2020
_version_ 1783724745521364992
author Jochmann, Anja
Trachsel, Daniel
Hammer, Jürg
author_facet Jochmann, Anja
Trachsel, Daniel
Hammer, Jürg
author_sort Jochmann, Anja
collection PubMed
description The prevalence of inflammatory bowel disease (IBD) has increased over the past 20 years. Pulmonary involvement in paediatric IBD is rare but may be missed since the spectrum of symptoms is broad and mimics other diseases. The most important differential diagnoses of pulmonary manifestations of IBD are infections and therapy-related side-effects. There is no gold standard to diagnose respiratory manifestations in children with IBD. Diagnostic tests should be chosen according to history and clinical presentation. Treatment of respiratory manifestations of IBD includes inhaled or oral corticosteroids and initiation or step-up of immunomodulatory IBD therapies.
format Online
Article
Text
id pubmed-8291939
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-82919392021-07-21 Inflammatory bowel disease and the lung in paediatric patients Jochmann, Anja Trachsel, Daniel Hammer, Jürg Breathe (Sheff) Reviews The prevalence of inflammatory bowel disease (IBD) has increased over the past 20 years. Pulmonary involvement in paediatric IBD is rare but may be missed since the spectrum of symptoms is broad and mimics other diseases. The most important differential diagnoses of pulmonary manifestations of IBD are infections and therapy-related side-effects. There is no gold standard to diagnose respiratory manifestations in children with IBD. Diagnostic tests should be chosen according to history and clinical presentation. Treatment of respiratory manifestations of IBD includes inhaled or oral corticosteroids and initiation or step-up of immunomodulatory IBD therapies. European Respiratory Society 2021-03 /pmc/articles/PMC8291939/ /pubmed/34295391 http://dx.doi.org/10.1183/20734735.0269-2020 Text en Copyright ©ERS 2021 https://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Reviews
Jochmann, Anja
Trachsel, Daniel
Hammer, Jürg
Inflammatory bowel disease and the lung in paediatric patients
title Inflammatory bowel disease and the lung in paediatric patients
title_full Inflammatory bowel disease and the lung in paediatric patients
title_fullStr Inflammatory bowel disease and the lung in paediatric patients
title_full_unstemmed Inflammatory bowel disease and the lung in paediatric patients
title_short Inflammatory bowel disease and the lung in paediatric patients
title_sort inflammatory bowel disease and the lung in paediatric patients
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291939/
https://www.ncbi.nlm.nih.gov/pubmed/34295391
http://dx.doi.org/10.1183/20734735.0269-2020
work_keys_str_mv AT jochmannanja inflammatoryboweldiseaseandthelunginpaediatricpatients
AT trachseldaniel inflammatoryboweldiseaseandthelunginpaediatricpatients
AT hammerjurg inflammatoryboweldiseaseandthelunginpaediatricpatients